FDA Maryland campus' environmental impact will be topic of Feb. 2 public meeting.
This article was originally published in The Gray Sheet
FDA MARYLAND CAMPUS' ENVIRONMENTAL IMPACT on Montgomery County will be discussed at a Feb. 2 public meeting headed by General Services Administration Development Director Jag Bhargava and FDA Deputy Commissioner for External Affairs Sharon Smith Holston. The meeting will be held at Gaithersburg High School, in Maryland, at 7:30 p.m. The government agencies expect the final environmental impact statement to be issued in late April or in May.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.